HONG (KEVIN) DING is a seasoned statistician specializing in oncology and clinical trials, currently serving as Statistical Science Associate Director at AstraZeneca since August 2020, providing statistical support for phase 1/2 clinical trials and overseeing CRO activities. Previously, HONG worked as Principal Biostatistician at Novartis from October 2015 to July 2020, focusing on phase 3 clinical trials in immunology and dermatology. HONG held the position of Senior Statistician at Johnson & Johnson from September 2013 to September 2015, contributing to the design of phase III oncology trials and generating integrated summaries for regulatory submissions. Earlier experience includes roles as a Biostatistician at Worldwide Clinical Trials, Inc. and MedImmune, where HONG engaged in the design and statistical analysis of various therapeutic areas including neurology and vaccine stability. HONG earned degrees from the University of Massachusetts Amherst and The George Washington University.
This person is not in any teams
This person is not in any offices